Veeva Sys Inc Stock Price, News & Analysis

Veeva Systems (NYSE: VEEV) announces its 2022 Veeva Industries Virtual Summit, scheduled for Oct. 24-27. Leaders from major companies like Unilever, Reckitt, and Estée Lauder will discuss digital strategies to boost innovation and accelerate product market entry. The event features over 15 sessions focused on leveraging digital systems in quality, regulatory, and advertising claims.

Experts will explore how these technologies enhance supply chain resilience and foster sustainable product development. Attendance is complimentary for Veeva customers and qualified professionals.

Veeva Systems (NYSE: VEEV) has announced that INCOG BioPharma Services has implemented the Veeva Vault Quality Suite at its new 90,000-square-foot facility in Pleasanton, CA. This suite facilitates seamless collaboration and transparency in manufacturing processes, enhancing operational efficiency and compliance. With the integration of various Veeva applications, INCOG aims to unify quality functions and streamline workflows, ultimately accelerating the delivery of injectable drugs. This partnership emphasizes the commitment to advancing quality management in the life sciences sector.

Veeva Systems (NYSE: VEEV) reported strong fiscal Q2 2023 results with total revenues of $534.2 million, a 17% increase year-over-year. Subscription services revenues also rose by 17% to $428.6 million. However, net income fell 17% to $90.6 million, resulting in a diluted net income per share of $0.56. Non-GAAP metrics showed improvements, with non-GAAP net income increasing 9% to $166.2 million. For fiscal Q3, Veeva forecasts revenues between $545 million and $547 million.

Veeva Systems announces that Veranex is utilizing Veeva Vault CDMS to enhance clinical data management, streamlining study builds and enabling mid-study amendments without downtime. This partnership allows Veranex to build complex studies rapidly and improve collaboration with clients, thus accelerating high-quality trial execution. As a comprehensive service provider in the medical technology sector, Veranex benefits from Veeva's innovative technology to address the complexities of clinical studies efficiently.

Veeva Systems will announce its financial results for the second quarter of fiscal 2023, ending July 31, 2022, on August 31, 2022, after market close. A conference call is scheduled for 2:00 p.m. PT to discuss these results. The company aims to communicate its performance and strategic outlook effectively to investors.

Veeva Systems (NYSE: VEEV) released the Veeva Pulse Field Trends Report, analyzing over 130 million quarterly healthcare professional (HCP) interactions across 80% of global biotech and pharma companies. The report highlights that video meetings are three times more effective than in-person interactions, with key digital channels crucial for HCP engagement. While 73% of interactions remain in-person, nearly 30% utilize digital channels, with significant regional differences noted. The data aims to guide companies in developing effective omnichannel engagement strategies.

The United States District Court for the Southern District of New York dismissed Medidata's trade secret misappropriation lawsuit against Veeva Systems (NYSE: VEEV) on July 15, 2022, ruling that Medidata failed to substantiate its claims. This ruling is pivotal for protecting employee rights and promoting competition in the life sciences sector. The court's decision highlighted that Medidata's lawsuit was an attempt to stifle innovation and intimidate employees. The dismissed suit has reportedly cost both companies about $40 million over five years.

ANI Pharmaceuticals and Veeva Systems have partnered to enhance commercial strategies for ANI's Rare Disease Business Unit, utilizing Veeva's data-driven tools. This collaboration aims to launch ANI's first product, Purified Cortrophin Gel, in the U.S. The companies emphasize agility and precision in addressing rare disease patients' needs. ANI has adopted Veeva Commercial Cloud solutions to strengthen its sales and marketing capabilities. This partnership is expected to refine customer engagement and optimize sales interactions, marking a significant step in ANI's mission to improve patient access.

Veeva Systems recently introduced Veeva Vault Study Training, a new application designed to unify learning management and clinical operations for enhanced clinical study training. This platform allows research sites, CROs, and sponsors to train trial staff efficiently and maintain real-time inspection readiness by automating training certificate filing. The application, available to early adopters in fall 2022, aims to streamline study execution and compliance, leveraging existing clinical data to minimize redundancy and manual tasks.